Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HYPERION DEFI, INC.EYEN · Entity 7220 | Chief Financial Officer | February 12, 2024 | February 14, 2024 |
| ORAGENICS INCOGEN · Entity 8495 | Director | December 11, 2025 | December 15, 2025 |
| Odyssey Health, Inc.ODYY · Entity 8618 | Former Director | January 10, 2024 | January 16, 2024 |
| electroCore, Inc.ECOR · Entity 6900 | Director | September 09, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HYPERION DEFI, INC.
Report date February 12, 2024 · Filed February 14, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.91 · Expires 2034-02-12 | Direct | 60,000 |
Reported balance
After 2024-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-02-12 · Grant · Acquired 60,000 · Balance 60,000 F1: One third of the option becomes exercisable on February 12, 2025 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: One third of the option becomes exercisable on February 12, 2025 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
ORAGENICS INC
Report date December 11, 2025 · Filed December 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Employee Director Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2035-12-11 | Direct | 125,000 |
Reported balance
After 2025-12-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-11 · Grant · Acquired 125,000 · Balance 125,000 F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.
Odyssey Health, Inc.
Report date January 10, 2024 · Filed January 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ODYY - Common StockSEC Table I · non-derivative | Direct | 1,738,792 |
Reported balance
After 2024-01-10 transaction · row 1
1 source rowRow 1 · 2024-01-10 · Grant · Acquired 1,500,000 · Balance 1,738,792 |
| Restricted Stock Unit (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.09 · Expires 2024-01-17 | Direct | 0 |
Reported balance
After 2024-01-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-01-10 · Disposition to issuer · Disposed 1,500,000 · Balance 0 |
electroCore, Inc.
Report date September 09, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,221 |
Reported balance
After 2026-09-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-09 · Grant · Acquired 11,123 · Balance 99,221 F1: Annual Deferred Stock Units award which vests in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting following the grant date, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. F2: Includes 84,032 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual Deferred Stock Units award which vests in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting following the grant date, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date.
F2: Includes 84,032 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:05 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantCommon Stock | 11,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-042145 · ownership.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,221 F1 · shares: Annual Deferred Stock Units award which vests in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting following the grant date, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. F2 · balance_after: Includes 84,032 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:31 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001200155-25-000004 · primary_doc.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-12-11 F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 16:05 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantCommon Stock | 19,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-012633 · ownership.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,098 F1 · shares: Annual Deferred Stock Units award which vests in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting following the grant date, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. F2 · balance_after: Includes 65,021 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant. Read SEC document |
| May 23, 2025 Filed May 27, 2025 09:27 UTC | electroCore, Inc. ECOR · Entity 6900 | PurchaseCommon Stock | 1,800 | $5.01 | $9,018.00 |
DisclosureSEC source: 0001641172-25-012413 · ownership.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,087 F1 · balance_after: Includes 59,493 shares vested pursuant to previously issued Deferred Stock Units (DSUs); and 5,528 shares issuable pursuant to DSUs that vest monthly through 9/3/2025; provided that such DSUs vest in full on the earlier of (i) one business day prior to the Issuer's next annual stockholder meeting, and (ii) the date immediately prior to a change of control, in each case, provided the Reporting Person remains in service with the Issuer through the applicable vesting date. Read SEC document |
| September 19, 2024 Filed Sep 21, 2024 01:15 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001493152-24-037729 · ownership.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-09-19 F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 21:31 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantCommon Stock | 16,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-24-001092 · e663868_4-gandolfo.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,287 F1 · shares: Represents a grant of Deferred Stock Units as a part of an annual director award which vest in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting following the grant date, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. F2 · balance_after: Includes 48,438 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 16:05 UTC | electroCore, Inc. ECOR · Entity 6900 | PurchaseCommon Stock | 1,000 | $6.43 | $6,430.00 |
DisclosureSEC source: 0001193805-24-000813 · e663724_4-gandolfo.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,704 F1 · balance_after: Includes 44,815 shares that have vested pursuant to previously issued Deferred Stock Units; 3,623 additional shares issuable pursuant to previously issued Deferred Stock Units will vest monthly through August 4, 2024, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. All such vested shares were previously reported on Form 4 filings at the time of grant. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:14 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001104659-24-023657 · tm245989-3_4seq1.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-02-12 F1 · derivative.exercise_date: One third of the option becomes exercisable on February 12, 2025 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| January 10, 2024 Filed Jan 16, 2024 17:10 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | Disposition to issuerRestricted Stock Unit (Right to Buy) · Derivative | 1,500,000 | $0.09 Strike: $0.09 | $135,000.00 |
DisclosureSEC source: 0001683168-24-000304 · ownership.xml · derivative · entry 2 GANDOLFO JOHN P · CIK 0001200155 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: ODYY Common Stock · 1,500,000 shares Expires 2024-01-17 Read SEC document |
| January 10, 2024 Filed Jan 16, 2024 17:10 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantODYY - Common Stock | 1,500,000 | $0.09 | $135,000.00 |
DisclosureSEC source: 0001683168-24-000304 · ownership.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,738,792 Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 20:33 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 5,102 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001493152-23-036522 · ownership.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,102 Underlying: Common Stock · 5,102 shares Expires 2033-10-04 F1 · security: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. F1 · derivative.exercise_date: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. F1 · balance_after: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 09:05 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantCommon Stock | 21,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-23-001122 · e618853_4-gandolfo.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,704 F1 · shares: Represents a grant of Deferred Stock Units as a part of an annual director award which vest in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting on or after January 1, 2024, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. F2 · balance_after: Includes 26,699 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant. Read SEC document |
| May 31, 2023 Filed May 31, 2023 18:31 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | PurchaseCommon Stock, par value $.0001 | 2,000 | $2.79 | $5,580.00 |
DisclosureSEC source: 0001104659-23-066718 · tm2317514-1_4seq1.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 16:02 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 68,235 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001415889-23-001053 · form4-01182023_090127.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,235 Underlying: Common Stock · 68,235 shares Expires 2033-01-17 F1 · derivative.exercise_date: One third of the option becomes exercisable on January 17, 2024 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 17:16 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantRestricted Stock Unit (Right to Buy) · Derivative | 500,000 | $0.30 Strike: $0.30 | $150,000.00 |
DisclosureSEC source: 0001683168-23-000192 · ownership.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: ODYY - Common Stock · 500,000 shares Expires not disclosed F1 · derivative.expiration_date: No expiration date Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:30 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantCommon Stock | 205,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-22-001657 · e618087_4-gandolfo.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,497 F1 · shares: Represents a grant of Deferred Stock Units as a part of an annual director award which vest in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting on or after January 1, 2023, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. F2 · balance_after: Includes 182,000 shares that have vested pursuant to previously issued Deferred Stock Units; 12,500 of such shares will vest monthly through April 2, 2023. All such vested and unvested shares were previously reported on Form 4 filings at the time of grant. Read SEC document |
| May 19, 2022 Filed Jun 8, 2022 17:17 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.30 Strike: $0.30 | $75,000.00 |
DisclosureSEC source: 0001683168-22-004241 · ownership.xml · derivative · entry 2 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 250,000 shares Expires 2032-05-18 Read SEC document |
| May 19, 2022 Filed Jun 8, 2022 17:17 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.30 Strike: $0.30 | $75,000.00 |
DisclosureSEC source: 0001683168-22-004241 · ownership.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 250,000 shares Expires 2032-05-19 Read SEC document |
| May 17, 2022 Filed May 18, 2022 08:30 UTC | electroCore, Inc. ECOR · Entity 6900 | PurchaseCommon Stock | 15,000 | $0.36 | $5,400.00 |
DisclosureSEC source: 0001193805-22-000826 · e621667_4-gandolfo.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 16:21 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Options (right to buy) · Derivative | 23,211 | $0.00 Strike: $3.10 | $0.00 |
DisclosureSEC source: 0001415889-22-001441 · form4-02162022_010202.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,211 Underlying: Common Stock · 23,211 shares Expires 2032-02-14 F1 · derivative.expiration_date: This stock option was granted by the Issuer's Board of Directors on February 14, 2022, subject to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan, as amended. One third of the option becomes exercisable on February 14, 2023 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 17:35 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantRestricted Stock Unit (Right to Buy) · Derivative | 500,000 | $0.45 Strike: $0.45 | $225,000.00 |
DisclosureSEC source: 0001683168-21-004319 · ownership.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 500,000 shares Expires not disclosed F1 · derivative.exercise_date: The vesting of the RSU (Units) is as follows: 500,000 RSU vest equally over 12 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction. F2 · derivative.expiration_date: No expiration. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 09:22 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 128,258 | $6.01 Strike: $6.01 | $770,830.58 |
DisclosureSEC source: 0001638599-21-000565 · doc4_7269.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,258 Underlying: Common Stock · 128,258 shares Expires not disclosed F1 · derivative.expiration_date: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 20:00 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantDeferred Stock Units · Derivative | 44,510 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-014476 · ownership.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,510 Underlying: Common Stock · 44,510 shares Expires 2031-06-11 F1 · derivative.exercise_date: The Deferred Stock Units vest in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting on or after January 1, 2022, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 16:30 UTC | electroCore, Inc. ECOR · Entity 6900 | PurchaseCommon Stock | 4,000 | $2.15 | $8,600.00 |
DisclosureSEC source: 0001213900-21-016082 · ownership.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 16:05 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | PurchaseCommon Stock, par value $.0001 | 4,000 | $3.40 | $13,600.00 |
DisclosureSEC source: 0001638599-20-000912 · doc4_6927.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:08 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 114,774 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001638599-20-000655 · doc4_6777.xml · derivative · entry 2 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,774 Underlying: Common Stock · 114,774 shares Expires 2030-06-02 F1 · derivative.exercise_date: This stock option was granted by the Issuer's Board of Directors on June 3, 2020, subject to stockholder approval of the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the Plan on June 30, 2020. One-third of the option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| April 02, 2020 Filed Apr 6, 2020 20:02 UTC | electroCore, Inc. ECOR · Entity 6900 | GrantDeferred Stock Units · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-010351 · doc4.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-04-02 F1 · derivative.exercise_date: The deferred stock units vest (i) in 36 equal monthly increments over a period of 36 months from the grant date, and (ii) in full on the date immediately prior to a change of control, in each case provided that the Reporting Person remains in continuous service with the Issuer or an affiliate through the applicable vesting date. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:20 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 53,402 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000789 · doc4_6252.xml · derivative · entry 2 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,402 Underlying: Common Stock · 53,402 shares Expires 2029-08-16 F1 · derivative.exercise_date: One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 17:33 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 24,842 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000810 · doc4_5544.xml · derivative · entry 2 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,842 Underlying: Common Stock · 24,842 shares Expires 2028-07-24 F1 · derivative.exercise_date: One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter. Read SEC document |
| June 28, 2018 Filed Jul 2, 2018 16:06 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | PurchaseCommon Stock, par value $.0001 | 2,000 | $5.86 | $11,720.00 |
DisclosureSEC source: 0001638599-18-000709 · doc4_5498.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 16:33 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 71,200 | $0.00 Strike: $8.72 | $0.00 |
DisclosureSEC source: 0001638599-18-000439 · doc4_5363.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,200 Underlying: Common Stock · 71,200 shares Expires 2028-04-16 F1 · derivative.exercise_date: The option becomes exercisable as to 1,977 shares on May 16, 2018, and becomes exercisable in equal 1,977 share amounts on each of the 35 one-month anniversaries thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.